Adjuvant Chemotherapy for Patients With Chronic Kidney Disease: A Study on Treatment Adoption and Associated Factors
Patients with CKD received adjuvant chemotherapy less frequently, likely owing to concerns about kidney toxicity and dose adjustments. Individualized treatment approaches are needed to optimize outcomes for this population.
Authors
- Yuichi Ichinose (ORCID: https://orcid.org/0000-0002-2474-785X)
- Taisuke Ishii (ORCID: https://orcid.org/0000-0002-7601-4295)
- Takahiro Higashi (ORCID: https://orcid.org/0000-0002-9933-2106)
- Tomone Watanabe (ORCID: https://orcid.org/0000-0002-8337-5005)
- Hiroyuki Mano (ORCID: https://orcid.org/0000-0003-4645-0181)
Institutions
- National Center for Global Health and Medicine (JP)
- Department of Health (IE)
- National Cancer Research Institute (GB)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/cam4.71237
- Primary Topic
- Chemotherapy-induced organ toxicity mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science